Sinopec Completes Construction of China's Largest Petrochemical Industrial Base

Sinopec Completes Construction of China's Largest Petrochemical Industrial Base

Refining Capacity of the Base Surpasses 50 Million Tons per Year NINGBO, China, Dec. 26, 2024 /PRNewswire/ -- China Petroleum & Chemical Corporation's (HKG: 0386, "Sinopec") recently announced the mechanical completion of the second-phase...

Great Bay Bio Completes First Close of Series B Financing

Great Bay Bio Completes First Close of Series B Financing

HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B financing round. This milestone was achieved with the round led by a syndication of a well-known strategic investment...

Minesto completes Hestfjord Dragon Farm specification based on Dragon 12 achievements

Minesto completes Hestfjord Dragon Farm specification based on Dragon 12 achievements

GOTHENBURG, Sweden, Dec. 10, 2024 /PRNewswire/ -- After successful commissioning and four months of grid connected operation with Dragon 12, this autumn Minesto has focused on evaluation of powerplant performance, analysis of critical technical...

TraceLink Successfully Completes Industry-Leading Audits: ISO/IEC 27001:2022, ISO/IEC 27017:2015, SOC 2/ISAE 3000 Type II, and CyberVadis

TraceLink Successfully Completes Industry-Leading Audits: ISO/IEC 27001:2022, ISO/IEC 27017:2015, SOC 2/ISAE 3000 Type II, and CyberVadis

Independent Audits Confirm TraceLink's Compliance with Leading Global Security Standards, Ensuring Customer Data Protection BOSTON, Dec. 9, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration...

Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations

Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations

BEIJING, Dec. 6, 2024 /PRNewswire/ -- Qi Biodesign, a biotechnology company pioneering next-generation genome editing technologies, announced the completion of its Series A funding round. The company has now raised a total of $75 million across its...

State Grid Kashgar Power Supply Company Successfully Completes 100th Live Working of the Year

State Grid Kashgar Power Supply Company Successfully Completes 100th Live Working of the Year

KASHGAR, China, Dec. 3, 2024 /PRNewswire/ -- On November 29, State Grid Kashgar Power Supply Company achieved a significant milestone by successfully completing its 100th live working operation of the year. This accomplishment underscores the...

EPAM Completes Strategic Acquisition of First Derivative, Enhancing AI and Data-Driven Solutions for Financial Services

EPAM Completes Strategic Acquisition of First Derivative, Enhancing AI and Data-Driven Solutions for Financial Services

Strategic acquisition strengthens EPAM's financial services delivery capabilities in North America, Europe and APAC, enhancing end-to-end services NEWTOWN, Pa. and NEWRY, N. Ireland, Dec. 3, 2024 /PRNewswire/ -- EPAM Systems, Inc. (NYSE: EPAM), a...

Aramco completes acquisition of 10% stake in Horse Powertrain Limited

Aramco completes acquisition of 10% stake in Horse Powertrain Limited

Following the signing of definitive agreements on June 28, 2024, Aramco has completed its acquisition of a 10% equity stake in Horse Powertrain Limited ("Horse Powertrain"), based on an enterprise value of €7.4 billion Renault Group and Geely...

CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China

CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China

CBC Group and Mubadala acquire UCB's mature neurology and allergy business in China for US$680 million. New company is named NeuroGen Pharma, led by an experienced management team with a strong track record in the biopharma industry. Strategic...

MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China

MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China

SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transitioning to oral Contezolid tablets for...

  • 1
  • 2
  • menu
    menu